Get informed when a big investor buys or sells
+ FollowUndervalued by 120.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $7.43 Billion |
|---|---|
| Enterprise Value | $7.13 Billion |
| Annual dividend | $0.14 |
| Dividend yield | 3.56% |
| Earnings per Share | $0.24 |
| Beta | 0.05 |
| Outstanding Shares | 1,905,191,901 |
| P/E Ratio | 23.48 |
|---|---|
| PEG | 21.55 |
| Price to Sales | 0.43 |
| Price to Book Ratio | 3.9 |
| Enterprise Value to Revenue | 0.4 |
| Enterprise Value to EBIT | 4.24 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.11 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Medibank Private Limited is an Australian firm specializing in private health insurance and health-related services. The company's operations are divided into two principal segments: Health Insurance and Medibank Health. The Health Insur...